Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
235.1 EUR | 0.00% | +3.11% | +32.82% |
Jul. 03 | Jerome Powell did it again | |
Jul. 03 | JPMorgan Chase Raises Price Target on Alnylam Pharmaceuticals to $248 From $160 | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- ALNY Stock
- DUL Stock
- Revisions Alnylam Pharmaceuticals, Inc.